HOME >> MEDICINE >> NEWS
Rapid diagnosis of mini-strokes saves time and money with no harm to patients

As many as 300,000 Americans per year are diagnosed with Transient Ischemic Attack (TIA, or "mini-stroke"). One of the difficulties with such patients is that by the time they reach the emergency room, their symptoms may have disappeared. Over 10% of these patients will suffer a stroke within 90 days, with 64% of those strokes being disabling, and 5% will experience a major cardiac event. Traditionally, these patients are admitted for a series of diagnostic tests over several days.

In a paper presented at the 2006 Society for Academic Emergency Medicine Annual Meeting, May 18-21, 2006 in San Francisco, researchers from William Beaumont Hospital and Wayne State University described a rapid protocol to evaluate TIA patients.

While there is consensus for rapid CT brain imaging, there is not agreement about the timing of other tests, such as carotid imaging. There is some interest in the use of an Accelerated Diagnostic Protocol (ADP), coupled with an Emergency Department Observational Unit, to avoid the average 3-day stay for admitted patients. This protocol may lower costs and reduce hospital stays, but questions remain about the outcomes and overall quality of care that such patients receive.

To address these and other questions, a controlled trial was conducted at Beaumont Hospital, Royal Oak, Michigan. After an initial evaluation and diagnosis of TIA, 149 patients were randomly assigned to the ADP group or to an inpatient hospital bed. All patients received the same 4 diagnostic tests (Carotid imaging, echocardiogram, cardiac monitoring, and serial clinical evaluation) but those in the ADP group received those tests more rapidly.

The median length of stay for the ADP group was 25 hours vs. 61 hours for the admitted patients, and their 90-day costs were $890 vs. $1547. Approximately 15% of the ADP patients were admitted and their length of stay averaged 100 hours with costs of $2737. While these cost savings are substantial, th
'"/>


18-May-2006


Page: 1 2

Related medicine news :

1. Rapid oral HIV test shows great promise according to MUHC-led research
2. Rapid response was crucial to containing the 1918 flu pandemic
3. Rapid flu testing is associated with decreased antibiotic use in hospitalized adults
4. Rapid flu tests may reduce threat of antibiotic resistance
5. Rapid expansion of HIV treatment services in Africa feasible, with good patient outcomes
6. Rapid lung function decline raises risk of death and hospitalization
7. Rapid emotional recovery of breast-cancer survivors surprises researchers
8. Rapid restoration of immunity in immune-suppressed cancer patients using T-cell vaccines
9. Using MRI for diagnosis could help prevent breast cancer progression
10. Medical management of another condition may not lead to early cancer diagnosis
11. TB test offers patients quicker and easier diagnosis

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Rapid diagnosis mini strokes saves time and money with harm patients

(Date:8/28/2014)... 2014 Kirklyn Smith, an office manager for ... a new world’s record by walking 5,000 miles in a ... constantly amazed by the thousands of individual stories of TrekDesk ... to stand out more than the others. , Kirklyn has ... count which tallies a range of 54,823 steps (presumably on ...
(Date:8/28/2014)... (HealthDay News) -- Lack of sleep not only puts teens ... increased risk for obesity, researchers warn. The study authors ... were aged 16 and 21. Nearly one-fifth of them got ... were age 16, and this group was 20 percent more ... got more than eight hours of sleep per night at ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 NJ ... Institute of North Jersey. , NJ Top Doc, ... is now a certified medical examiner for the ... certified by the department to perform all drug ... training in diagnosing and treating musculoskeletal disorders including ...
(Date:8/28/2014)... In 2012, The Ben & Catherine Ivy Foundation ... brain cancer research projects at the Translational Genomics ... officially received the final regulatory approval from University ... for the trial can begin. , In the ... Trial," TGen and its clinical partners will lead ...
(Date:8/28/2014)... August 28, 2014 As Mirena IUD ... around the U.S., Bernstein Liebhard LLP notes that a ... like Mirena as ideal birth control for teenage girls. ... authors of the study point out that IUDs are ... other methods favored by this patient population. Their study, ...
Breaking Medicine News(10 mins):Health News:There are many reasons why Americans' exercise levels have declined - Meet an executive that refuses to sit still with his TrekDesk Treadmill Desk even in a sedentary job 2Health News:Less Sleep in Teen Years Tied to More Pounds at 21 2Health News:NJ Top Docs Presents Dr. Christophe Oliveira of Rehabilitation Instiute of North Jersey 2Health News:NJ Top Docs Presents Dr. Christophe Oliveira of Rehabilitation Instiute of North Jersey 3Health News:TGen receives approval for patient enrollment in brain cancer clinical trial 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Notes New Study Touting IUDs as Ideal Birth Control for Teenage Girls 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Notes New Study Touting IUDs as Ideal Birth Control for Teenage Girls 3Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Notes New Study Touting IUDs as Ideal Birth Control for Teenage Girls 4
(Date:8/28/2014)... Aug. 28, 2014  In recognition of the increased ... from the flu, pneumonia, shingles and other illnesses, ... declared September to be Senior Vaccination Month. Because ... is important that adults ages 65 years and ... CVS pharmacists and MinuteClinic nurse practitioners and physician ...
(Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire/ ... market research report is available in ... Therapeutics in Asia-Pacific Markets to 2020 ... Unmet Need in Newly Diagnosed and ... http://www.reportlinker.com/p02343492/Glioblastoma-Multiforme-Therapeutics-in-Asia-Pacific-Markets-to-2020---Novel-Therapeutic-Approaches-Target-High-Unmet-Need-in-Newly-Diagnosed-and-Recurrent-GBM.html Glioblastoma ...
(Date:8/28/2014)... , Aug. 28, 2014 Telik, Inc. ... company that merged with MabVax Therapeutics, Inc. on ... significant progress related to the development of its ... was recovered using the Company,s internally developed antibody ... potential for multiple antibody based therapeutic and diagnostic ...
Breaking Medicine Technology:September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 4Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 2Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 3Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 4Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 5Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 6Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 7Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 8Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 9Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 2Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 4
Cached News: